Kate Carruthers advises in domestic and cross-border M&A transactions, a range of strategic emerging growth and technology transactions, corporate governance, and general corporate matters. Her clients range in size from Fortune 500 public companies to medical technology start-ups, and she has experience advising clients across various industries including food, consumer products, chemicals, and manufacturing.
Kate's representative matters include: Eastman Chemical Company's $1 billion cross-border carve-out divestiture of its adhesives resins business; transactions for Roper Technologies (including Roper's sale of its industrial businesses within its Measurement & Analytical Solutions segment to Clayton Dubilier & Rice, LLC); BioMarin Pharmaceutical's negotiation of a Cooperation Agreement and Information Sharing Agreement with activist shareholder Elliott Management; and restor3d, Inc.'s Series A Preferred Stock Offering in an aggregate capital amount of up to $50 million.
- University of Georgia (J.D. cum laude 2019; Articles Editor, Georgia Law Review); University of Virginia (B.A. in Religious Studies and English with distinction 2016; Echols Scholar)
- Georgia